Hypertension. II

January 1971
British Medical Journal;1/9/1971, Vol. 1 Issue 5740, p99
Academic Journal
No abstract available.


Related Articles

  • valsartan.  // Taber's Cyclopedic Medical Dictionary;2005, p2293 

    A definition of the term "valsartan" is presented. It refers to an angiotensin II receptor antagonist and hypertensive, administered orally to manage hypertension.

  • Aliskiren combination therapy helped improve systolic BP.  // Cardiology Today;Jun2010, Vol. 13 Issue 6, p32 

    The article discusses the studies about the effectiveness of a combination hypertension therapy in systolic blood pressure in stage II hypertension patients with and without diabetes.

  • Olmesartan (Benicar) for Hypertension. Ward, Kristina E.; Hume, Anne I. // American Family Physician;8/15/2005, Vol. 72 Issue 4, p673 

    Provides information on olmesartan, an angiotensin-II receptor blocker labeled for the treatment of hypertension. Tolerability of the drug; Effectiveness in patients with hypertension; Recommended starting dosage.

  • ACE inhibitor effectively prevents macroalbuminuria.  // Modern Medicine;Jan94, Vol. 62 Issue 1, p72 

    Presents an abstract of the article entitled `Captopril or Conventional Therapy in Hypertensive Type II Diabetes: Three-Year Analysis Hypertension,' by Y. Lacourciere, A. Nadeau, et al, published in the June 1993 issue of the periodical `Hypertension.'

  • Angiotensin blockade in hypertension. Streeten, David H. P.; Anderson, Gunnar H.; Streeten, D H; Anderson, G H // Annals of Internal Medicine;Mar77, Vol. 86 Issue 3, p353 

    Editorial. Comments on the excessive angiotensin II activity as the cause of some types of hypertension in human. Details of the report on the blood pressure responses of several hypertensive patients; Saralasin as a competitive antagonist of the action of angiotensin II; Contribution of...

  • Angiotensin II in essential hypertension. Beevers, D.G.; Morton, J.J.; Nelson, C.S.; Padfield, P.L.; Titterington, M.; Tree, M. // British Medical Journal;2/12/1977, Vol. 1 Issue 6058, p415 

    Evaluates the measurement of plasma concentration angiotensin II in hypertensive patients in Renfrew, Scotland. Absence of bimodality in the frequency distribution of angiotensin II; Estimation of urinary sodium in patients; Evaluation of the renin-angiotensin system in hypertension.

  • Telmisartan: A Viewpoint by Norman Sharpe. Sharpe, N. // Drugs;Dec1998, Vol. 56 Issue 6, p1045 

    Discusses the use of the angiotensin II receptor antagonist telmisartan in the management of hypertension and congestive heart failure. Use of angiotensin converting enzyme inhibitors in hypertension; Mechanism of action of angiotensin II receptor antagonist.

  • Hypertension, Angiotensin II, and Oxidative Stress. Sowers, James R. // New England Journal of Medicine;6/20/2002, Vol. 346 Issue 25, p1999 

    Discusses hypertension, angiotensin II, and oxidative stress. How renovascular hypertension is a potentially curable form of secondary hypertension generally due to either atherosclerosis or fibromuscular dysplasia of one or both renal arteries; Evidence that suggests angiotensin II increases...

  • Interplay of Hypertension, Inflammation, and Angiotensin II. Lahera, Vicente; Cachofeiro, Victoria; de las Heras, Natalia // American Journal of Hypertension;Oct2011, Vol. 24 Issue 10, p1059 

    The article discusses the demonstration of Chamarthi and colleagues in the interrelation between hypertension, inflammation, and angiotensin II. It notes the association of hypertension and enhanced inflammatory mediator C-reactive protein (CRP) and cytokines. It also highlights the importance...

  • Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation. Dodson, P.M.; Beevers, M.; Hallworth, R.; Webberley, M.J.; Fletcher, R.F.; Taylor, K.G. // BMJ: British Medical Journal (International Edition);1/28/89, Vol. 298 Issue 6668, p227 

    Examines the effect of moderate dietary sodium restriction on the hypertension of non-insulin-dependent (type II) diabetes. Reduction of blood pressure in type II diabetics with mild hypertension; Decrease of the number of patients receiving anti-hypertensive drug treatment; Influence of sodium...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics